One of the ARK exchange-traded funds run by ETF star Cathie Wood made huge sale on Wednesday. This fund sold over 125,000 shares of Iovance Biotherapeutics Inc. (NASDAQ: IOVA) shares, as the price of this ETF was flat on Wednesday. Note that this ETF is still up handily in the past year.
ARK Innovation ETF (NYSEARCA: ARKK) sold 128,163 shares of Iovance. At Wednesday’s closing price, this would have valued this sale at $3 million. Even though this is a small fraction of the total holdings, every little bit counts. The fund is up 37% in the past year.
Check out all of the ARK Invest sales for Wednesday:
| Fund | Ticker | Name | Shares |
|---|---|---|---|
| ARKF | 3690HK | MEITUAN | 1,342,426 |
| ARKF | 9923HK | YEAHKA | 339,600 |
| ARKF | 6060HK | ZHONGAN ONLINE P&C INSURANCE | 1,339,400 |
| ARKG | SEER | SEER | 152,557 |
| ARKG | RHHBY | ROCHE | 66,000 |
| ARKG | PSTI | PLURISTEM THERAPEUTICS | 16,223 |
| ARKG | BMY | BRISTOL-MYERS SQUIBB | 114,400 |
| ARKK | IOVA | IOVANCE BIOTHERAPEUTICS | 128,163 |
| ARKK | NTDOY | NINTENDO | 53,300 |
| ARKQ | XONE | EXONE | 82,333 |
| ARKW | LC | LENDINGCLUB | 164,932 |
| ARKW | NFLX | NETFLIX | 192 |
Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24/7 Wall St.
Sponsored: Attention Savvy Investors: Speak to 3 Financial Experts – FREE
Ever wanted an extra set of eyes on an investment you’re considering? Now you can speak with up to 3 financial experts in your area for FREE. By simply clicking here you can begin to match with financial professionals who can help guide you through the financial decisions you’re making. And the best part? The first conversation with them is free.Click here to match with up to 3 financial pros who would be excited to help you make financial decisions.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
